The Triple Effect Of Community-Based Clinical Trials

By Jeff Huntsman, Chief Commercial Officer

Community-based clinical trials are reshaping how research reaches patients by embedding study sites within local healthcare settings and trusted community environments. This model maintains the same regulatory rigor as traditional trials but changes execution in ways that remove long-standing barriers to participation. By reducing travel demands and integrating familiar care teams, clinical trials can engage broader and more diverse populations that have historically been underrepresented.

The impact goes beyond access. Expanding reach drives faster enrollment, while improved patient experience helps reduce dropout rates and keep studies on track. At the same time, participation from more representative populations strengthens the quality and relevance of data, supporting growing regulatory expectations for real-world evidence. As pressure mounts to accelerate timelines and improve outcomes, community-based approaches are emerging as a practical, scalable path forward.

Uncover how rethinking trial delivery can unlock more efficient, inclusive, and data-rich research.